These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 30303592

  • 1. Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence.
    Arena A, Zimmer TS, van Scheppingen J, Korotkov A, Anink JJ, Mühlebner A, Jansen FE, van Hecke W, Spliet WG, van Rijen PC, Vezzani A, Baayen JC, Idema S, Iyer AM, Perluigi M, Mills JD, van Vliet EA, Aronica E.
    Brain Pathol; 2019 May; 29(3):351-365. PubMed ID: 30303592
    [Abstract] [Full Text] [Related]

  • 2. Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Sun FJ, Zhang CQ, Chen X, Wei YJ, Li S, Liu SY, Zang ZL, He JJ, Guo W, Yang H.
    J Neuroinflammation; 2016 Apr 19; 13(1):85. PubMed ID: 27095555
    [Abstract] [Full Text] [Related]

  • 3. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Yue J, Zhang C, Shi X, Wei Y, Liu L, Liu S, Yang H.
    Brain Dev; 2019 Nov 19; 41(10):829-838. PubMed ID: 31495513
    [Abstract] [Full Text] [Related]

  • 4. Chronic activation of anti-oxidant pathways and iron accumulation in epileptogenic malformations.
    Zimmer TS, Ciriminna G, Arena A, Anink JJ, Korotkov A, Jansen FE, van Hecke W, Spliet WG, van Rijen PC, Baayen JC, Idema S, Rensing NR, Wong M, Mills JD, van Vliet EA, Aronica E.
    Neuropathol Appl Neurobiol; 2020 Oct 19; 46(6):546-563. PubMed ID: 31869431
    [Abstract] [Full Text] [Related]

  • 5. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.
    Talos DM, Sun H, Kosaras B, Joseph A, Folkerth RD, Poduri A, Madsen JR, Black PM, Jensen FE.
    Ann Neurol; 2012 Apr 19; 71(4):539-51. PubMed ID: 22447678
    [Abstract] [Full Text] [Related]

  • 6. Altered expression of the Plexin-B2 system in tuberous sclerosis complex and focal cortical dysplasia IIb lesions.
    Dai L, Huang J, Shen KF, Yang XL, Zhu G, Zhang L, Wang ZK, Liu SY, Liao X, Xu SL, Yang H, Li XY, Zhang CQ.
    Histol Histopathol; 2024 Sep 19; 39(9):1179-1195. PubMed ID: 38293776
    [Abstract] [Full Text] [Related]

  • 7. Dysregulation of the (immuno)proteasome pathway in malformations of cortical development.
    van Scheppingen J, Broekaart DW, Scholl T, Zuidberg MR, Anink JJ, Spliet WG, van Rijen PC, Czech T, Hainfellner JA, Feucht M, Mühlebner A, van Vliet EA, Aronica E.
    J Neuroinflammation; 2016 Aug 26; 13(1):202. PubMed ID: 27566410
    [Abstract] [Full Text] [Related]

  • 8. Downregulated formyl peptide receptor 2 expression in the epileptogenic foci of patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Huang K, Wang Z, He Z, Li Y, Li S, Shen K, Zhu G, Liu Z, Lv S, Zhang C, Yang H, Yang X, Liu S.
    Immun Inflamm Dis; 2022 Nov 26; 10(11):e706. PubMed ID: 36301030
    [Abstract] [Full Text] [Related]

  • 9. Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress.
    Zimmer TS, Korotkov A, Zwakenberg S, Jansen FE, Zwartkruis FJT, Rensing NR, Wong M, Mühlebner A, van Vliet EA, Aronica E, Mills JD.
    Brain Pathol; 2021 Sep 26; 31(5):e12949. PubMed ID: 33786950
    [Abstract] [Full Text] [Related]

  • 10. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.
    Nguyen LH, Mahadeo T, Bordey A.
    J Neurosci; 2019 Apr 03; 39(14):2762-2773. PubMed ID: 30700531
    [Abstract] [Full Text] [Related]

  • 11. Expression of bone morphogenetic protein-4 in the cortical lesions of focal cortical dysplasia IIb and the tuberous sclerosis complex.
    Guo W, Zhang CQ, Shu HF, Yang MH, Yin Q, Yang H.
    J Mol Neurosci; 2013 May 03; 50(1):7-13. PubMed ID: 22752548
    [Abstract] [Full Text] [Related]

  • 12. [Expression of autophagy-related proteins in malformations of cortical development].
    Chen S, Piao Y, Fu Y, Li Z, Liu C, Lu D.
    Zhonghua Bing Li Xue Za Zhi; 2015 May 03; 44(5):305-9. PubMed ID: 26178210
    [Abstract] [Full Text] [Related]

  • 13. Downregulated GPR30 expression in the epileptogenic foci of female patients with focal cortical dysplasia type IIb and tuberous sclerosis complex is correlated with 18 F-FDG PET-CT values.
    Wang Z, Huang K, Yang X, Shen K, Yang L, Ruan R, Shi X, Wang M, Zhu G, Yang M, Zhang C, Lv S, Yang H, Fan X, Liu S.
    Brain Pathol; 2021 Mar 03; 31(2):346-364. PubMed ID: 33314369
    [Abstract] [Full Text] [Related]

  • 14. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
    Boer K, Lucassen PJ, Spliet WG, Vreugdenhil E, van Rijen PC, Troost D, Jansen FE, Aronica E.
    Epilepsia; 2009 Dec 03; 50(12):2629-37. PubMed ID: 19583781
    [Abstract] [Full Text] [Related]

  • 15. Characteristic expression of p57/Kip2 in balloon cells in focal cortical dysplasia.
    Kimura T, Kitaura H, Masuda H, Kameyama S, Saito Y, Sugai K, Otsuki T, Nakazawa A, Morota N, Yamamoto T, Iida K, Nakagawa M, Mizuno T, Takahashi H, Kakita A.
    Neuropathology; 2015 Oct 03; 35(5):401-9. PubMed ID: 25950494
    [Abstract] [Full Text] [Related]

  • 16. Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex.
    Scholl T, Mühlebner A, Ricken G, Gruber V, Fabing A, Samueli S, Gröppel G, Dorfer C, Czech T, Hainfellner JA, Prabowo AS, Reinten RJ, Hoogendijk L, Anink JJ, Aronica E, Feucht M.
    Brain Pathol; 2017 Nov 03; 27(6):770-780. PubMed ID: 27750396
    [Abstract] [Full Text] [Related]

  • 17. Abnormal maturation and differentiation of neocortical neurons in epileptogenic cortical malformation: unique distribution of layer-specific marker cells of focal cortical dysplasia and hemimegalencephaly.
    Arai A, Saito T, Hanai S, Sukigara S, Nabatame S, Otsuki T, Nakagawa E, Takahashi A, Kaneko Y, Kaido T, Saito Y, Sugai K, Sasaki M, Goto Y, Itoh M.
    Brain Res; 2012 Aug 27; 1470():89-97. PubMed ID: 22759905
    [Abstract] [Full Text] [Related]

  • 18. Cell injury and premature neurodegeneration in focal malformations of cortical development.
    Iyer A, Prabowo A, Anink J, Spliet WG, van Rijen PC, Aronica E.
    Brain Pathol; 2014 Jan 27; 24(1):1-17. PubMed ID: 23586324
    [Abstract] [Full Text] [Related]

  • 19. PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia.
    Jansen LA, Mirzaa GM, Ishak GE, O'Roak BJ, Hiatt JB, Roden WH, Gunter SA, Christian SL, Collins S, Adams C, Rivière JB, St-Onge J, Ojemann JG, Shendure J, Hevner RF, Dobyns WB.
    Brain; 2015 Jun 27; 138(Pt 6):1613-28. PubMed ID: 25722288
    [Abstract] [Full Text] [Related]

  • 20. FCD Type II and mTOR pathway: Evidence for different mechanisms involved in the pathogenesis of dysmorphic neurons.
    Rossini L, Villani F, Granata T, Tassi L, Tringali G, Cardinale F, Aronica E, Spreafico R, Garbelli R.
    Epilepsy Res; 2017 Jan 27; 129():146-156. PubMed ID: 28056425
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.